Summary The biodistribution of two recently developed tumour markers, trimethylated (CP(Me)3) and trimethoxylated (CP(OMe)3) carotenoporphyrin, was investigated by means of laser-induced fluorescence (LIF) after i.v. injection into 38 tumour-bearing (MS-2 fibrosarcoma) female Balb/c mice. At 3, 24, 48 or 96 h after administration, the carotenoporphyrin fluorescence was measured in tumoral and peritumoral tissue, as well as in the abdominal, thoracic and cranial cavities. The fluorescence was induced by a nitrogen laser-pumped dye laser, emitting light at 425 nm, and analysed by a polychromator equipped with an image-intensified CCD camera. The fluorescence was evaluated at 490, 655 and 720 nm: the second and third wavelengths represent the carotenoporphyrin (CP)-related peaks, whereas the first one is close to the peak of the tissue autofluorescence. The tumour and the liver were the two tissue types showing the strongest carotenoporphyrin-related fluorescence, whereas the cerebral cortex and muscle consistently exhibited weak substance-related fluorescence. In most tissue types, the fluorescence intensities decreased over time. A few exceptions were observed, notably the liver, in which the intensity remained remarkably constant over the time period investigated.
One of the most important factors for successful treatment of malignant tumours is early detection. Therefore, the development of new techniques for more sensitive and less invasive tumour diagnosis is desirable. Laser-induced fluorescence (LIF) is a promising and rapidly developing technique by which the fluorescence from endogenous as well as exogenously administered fluorophores is investigated (Profio, 1990; Andersson-Engels et al, 1992) . It has been shown that the fluorescence emission is altered very early in the tissue transformation into malignancy (Lam et al, 1990 ; Baert et al, 1992) . The laser is ideal as an excitation source, as the light emitted is monochromatic and can be coupled efficiently into an optical fibre. Optical fibres can easily be inserted into a regular white-light endoscope for investigations of the tracheobronchial area, the urinary bladder or the gastrointestinal system. In addition to using a single optical fibre for point measurements, larger areas can be imaged by means of CCD cameras and imaging fibre bundles. Using a split-mirror telescope, the fluorescence can be imaged at several wavelengths simultaneously. With computer processing, real-time images with an enhanced tumour contrast can be obtained ). This appears to be an attractive modality for early tumour detection in endoscopically reachable organs, in which larger areas can be investigated at once, yielding colour-coded images of a tumour region.
LIF diagnostics has been based primarily on the fact that porphyrins, and certain derivatives thereof, are accumulated in malignant neoplastic tissue and that they emit a characteristic fluorescence profile when excited with light in the ultraviolet (UV) or near-UV wavelength region, usually with a dual-peaked emission in the red wavelength region above 600 nm. Apart from the substance-related fluorescence, an autofluorescence signal in the blue-green region, peaking at about 500 nm, is also seen. The endogenous fluorescence is emitted from the excitation of connective tissue matrix proteins, such as collagen and elastin, and also from co-factors in the cell respiration, namely the redox pair NADH/NAD+, as well as various flavins. It has been reported repeatedly that the intensity of the autofluorescence is low in malignant tumours compared with non-transformed surrounding tissues (see, for example, Ankerst et al, 1984; Svanberg et al, 1986) . This is sometimes attributed to a change in the equilibrium between NADH and NADH+ due to the decreased pH in most tumours (Andersson-Engels et al, 1990) . The reduced fluorescence intensity can very favourably be included in the diagnostic criterion, thus enhancing the demarcation between malignant neoplasia and healthy tissue.
Haematoporphyrin derivatives (HpDs) and other substances with a tetrapyrrole ring structure have primarily been developed for use in photodynamic therapy (PDT). It is well known that HpD and other sensitizers are accumulated to a certain degree in the skin and, therefore, the patients have to avoid ambient daylight for some time after administration. Thus, for fluorescence diagnostics, the photodynamic action is an undesired effect. This dilemma has partly been solved by using the drugs at lower doses (Lam et al, 1990; Baert et al, 1992 Wavelength (nm) Figure 2 Laser-induced fluorescence spectra of (A) liver, (B) small intestine and (C) heart, all 3 h after i. (Moore et al, 1982; Gust et al, 1992a) . Hence, the CP is mimicking carotenoid photoprotection such as found in the green plant photosynthetic reaction centres. Further, if '02 from any source is present, the 102 is deactivated by the carotenoid moiety via the energy transfer process: 102+ carotenoid -+ 3°+ 3carotenoid (Cogdell and Frank, 1987) . These favourable properties of CPs suggest that they could be potential candidates for clinical in vivo LIF diagnostics .
MATERIALS AND METHODS Chemicals
One trimethylated (CP(Me)3) and one trimethoxylated (CP(OMe)3) carotenoporphyrin was used in the experiments. These substances were synthesized according to a procedure previously described by Gust et al (1992b mimic the in vivo situation to as great an extent as possible. In the abdomen, the organs responsible for excretion of the substances, the liver and the intestines (i.e. excretion via the hepatobiliary route) , were analysed, as well as the kidneys and the urinary bladder. In some animals, the bladder was full of urine, whereas in others it was half-full or completely empty, as a result of either urination or manual emptying by the investigators.
The fluorescence of the stomach was also measured, but none of the values obtained was processed because of a very strong fluorescence peak at about 670 nm and another one above 700 nm, interfering with the carotenoporphyrin fluorescence peaks at 655 and 720 nm. Furthermore, in most spectra captured from the large and small intestine, on the surface of the skin, and on the abdominal muscle wall, a fluorescence peak at about 670 nm caused strong interference with the carotenoporphyrin fluorescence peaks. The fluorescence from the spleen, lungs, heart and the trachea was also measured. Finally, the calvarium was removed and the underlying cerebral cortex was probed.
In the presence of blood, the fluorescence signal was severely distorted as a result of the strong reabsorption by haemoglobin at 540 and 580 am. The interaction of haemoglobin was particularly prominent when monitoring the lungs, spleen and trachea. This was also evident in the necrotic tumours, where haemorrhages occurred when measurements were made of the interior part of the tumours (Nilsson et al, 1994) . Sometimes this interference was evident on probing the exterior capsule of the tumour, because of subcapsular haemorrhages, again due to tumour necrosis. RESULTS Figure 2A shows a typical fluorescence spectrum from liver tissue recorded 3 h after administration of CP(Me)3 with the dual-peaked substance-related fluorescence at about 655 and 720 nm. The background-free substance-related peak of CP(Me)3, located at about 654 nm, is denoted A in the figure.
The autofluorescence, denoted B, was evaluated at 490 nm. For CP(OMe)3, the main peak is located at 658 nm and the second peak at about 722 nm. The background-free main peak is also in this case denoted A. The differences between the recorded spectra were seen in the intensity at the peak wavelengths for CP as well as the endogenous fluorescence profiles for the different organs. In some organs, additional fluorescence peaks were detected. In the gastrointestinal system, the skin and the abdominal wall, a prominent peak at 672 nm and interference above 700 nm were observed ( Figure 2B ). This feature will be discussed below. Also, in the spectra recorded from the heart and some of the tumours, a peak at approximately 596 nm was seen ( Figure 2C ). Finally, in a few cases, a peak at around 630 nm was detected ( Figure 2D ).
British Journal of Cancer (1997) The data represent an average of the background-free fluorescence intensities at 654 nm (A) divided by the autofluorescence, evaluated at 490 nm (B) for the various organs (i.e. ANB), expressed in units relative to the average value for tumour exterior, which is set to 1. The bars indicate ± one standard deviation Figure 3 presents the data obtained during the measurements on CP(Me)3, at 3, 24, 48 and 96 h after i.v. injection. The y-axes display the fluorescence intensities at 654 nm (A) for the various tissues, expressed in units relative to tumour exterior (i.e. measurements on the tumours after removal of the overlying skin ; Nilsson et al, 1994) . The value of tumour exterior is set to unity. The figures printed in bold face above the dashed lines represent multiplication factors, relating the measurements at the different time points to each other. In some of the graphs, a few values have been deleted as a result of interference by non-substance-related peaks. This phenomenon is especially prominent for the non-substancerelated peak at 672 nm, which interferes with the A peak. No single point is based on fewer than two recordings. The vertical bars indicate ± one standard deviation. In some cases, there were no values at all at a specific location for a specific subgroup of mice. For example, at 3 h, all the mice of this subgroup had urinary bladders that were full of urine, and no mouse had an empty bladder. However, for the sake of consistency, all x-axes are labelled similarly. This same reasoning holds true for Figure 4 , with the only difference being that this figure depicts the data collected from the mice injected with CP(OMe)3.
It has previously been shown that the recorded CP fluorescence from tumour exterior increases over the first 48 h, and then drops during the consecutive 48 h, to reach a low level at 96 h after injection (Nilsson et al, 1994; Reddi et al, 1994) . It can be concluded from Figure 3 that no organ except the liver exhibits a stronger CP(Me)3 fluorescence at 654 nm than does the tumour exterior. For the liver, the substance-related fluorescence intensity at 654 nm remains almost constant over time ( Figure 5 ). The spleen, on the other hand, follows the pattern of the tumour exterior, increasing up to 48 h and then falling off during the next 48 h. The kidney has a decreasing profile over the whole period. An organ that only exhibited a minute fluorescence intensity at 654 nm, in all four batches, was the cerebral cortex. Another interesting point is that the empty bladder exhibits a more intense (A) fluorescence than the full bladder. On the other hand, the full bladders exhibited a very strong autofluorescence, peaking between 520 and 530 nm, which is not seen in the empty bladders. The trachea and the lung displayed a decreasing pattern, similar to the kidney.
Figures 4 and 6 show the corresponding data for CP(OMe)3. The interference from non-substance-related peaks, described for Figure 3 , is not as prominent in Figure 4 , probably because of a higher accumulation of the trimethoxylated carotenoporphyrin or because of a higher fluorescence yield, which allows the substance-related fluorescence to dominate over other fluorescence signatures. In the case of CP(OMe)3, tumour exterior exhibits its British Journal of Cancer (1997) strongest 658 nm fluorescence 3 h after administration of the substance and then the intensity slowly decreases over time (Nilsson et al, 1994) . As in the case of CP(Me)3, the liver is the only organ with a substance-related fluorescence similar to that of tumour exterior. The liver fluorescence is approximately equal between 3 and 24 h and then falls off to approximately one half the original peak intensity at the 48 and 96 h measurements ( Figure 6 ). The fluorescence intensity obtained on probing the spleen increases at 658 nm between 3 and 24 h, and decreases after that. The renal fluorescence follows the same trend as in Figure 3 , i.e. the peak intensity has its maximum at 3 h and then decreases over time. The small intestine, lung and trachea yield high initial fluorescence intensities at 658 nm, which are quickly reduced, as demonstrated by measurements after the 3-h batch. Finally, only a very low fluorescence intensity is obtained at all times when probing the cerebral cortex.
In Figures 7 and 8 , the ratio of the carotenoporphyrin-related fluorescence to the autofluorescence is presented for the different organs and for the two different substances. The ratio is higher for tumour than for any other of the studied organs. This is because of a decrease of the autofluorescence intensity in the tumour, as has been shown previously (Ankerst et al, 1984; Hung et al, 1991) .
DISCUSSION
The two CPs used in this study are good tumour localizers with fluorescence signatures that are easily detectable. In general, the overall pattern of the biodistribution data presented herein is in very good agreement with that obtained by chemical extraction studies ) although a few discrepancies between the in vivo/ex vivo and in vitro analytical methods can be distinguished. Reddi et al (1994) showed that the spleen accumulates large amounts of both substances. In our study, however, it is not evident that this is the case. The reason for this is probably that organs rich in blood, such as the spleen, the lungs and to some extent the kidneys, exhibit a severely reduced fluorescence signal, principally because of absorption of the excitation light and reabsorption of the fluorescence by haemoglobin (Hb). Since the Soret absorption band for HbO2 is located at 420 nm and the excitation wavelength used was 425 nm, the absorption is very prominent.
Further, the two absorption Q-bands at 540 and 580 nm for HbO2 did interfere with the autofluorescence signal in the green-yellow spectral region in some cases, creating 'reabsorption dips' in the corresponding fluorescence spectra.
British Journal of Cancer (1997) The behaviour of the CPs is quite typical of porphyrin derivatives administered by way of hydrophobic delivery systems and eliminated via the hepatobiliary route, as indicated by the large amounts of the substances accumulated in the liver and spleen (Jori, 1987) . Further indications of this can be found in Figure 4 , in which the small intestine exhibits a high fluorescence at the wavelength of the main peak A at 3 h and, to some degree, at 24 h. Figures 3 and 4 also show that only very small amounts of CPs seem to cross the blood-brain barrier and reach the cerebral cortex, as illustrated by the low substance-related fluorescence intensities at all times for this organ. The pattern of CP(OMe)3-related fluorescence retrieved from the lung and trachea, with a high initial intensity soon followed by a marked reduction, could be because of trapping in the microvasculature of these organs (Alian et al, 1994) . This process could either be an active accumulation in the reticuloendothelial cells or a passive trapping. Theoretically, the CPs could traverse the plasma membranes of the endothelial cells because of the relatively hydrophobic nature of these compounds.
Figures 7 and 8 clearly point out the benefits of using the ratio of the background-free substance-related fluorescence and the autofluorescence for tumour demarcation purposes. Tumour exterior exhibits a ratio that is at least a factor of 2 greater than it is for any other organ, with very few exceptions. This fact holds true for both CPs. The tumour to normal surrounding muscle ratio has previously been found to range from 8:1 to 10:1 for CP(Me)3 and from 9:1 to 12:1 for CP(OMe)3, when including the autofluorescence in the discrimination criterion (Nilsson et al, 1994) . Figures 3, 4, 7 and 8 show that the substance-related fluorescence was higher in the measurements of the empty bladders than of the full ones, whereas the endogenous fluorescence was much dominant in the case of the full bladders. A possible explanation for this is that when measuring on the empty bladders only the detrusor muscle is probed, whereas in the case of the full bladders both the urine and the muscular bladder wall are subjected to measurement. Thus, this fact can be taken to point out the lack of significant renal excretion of, at least, the intact CPs. The above-mentioned figures also indicate that the detrusor muscle appears to accumulate more CP than plain skeletal muscle, as shown by the more intense (A) fluorescence in the empty bladder than in thigh/leg muscle.
As has been mentioned earlier, a few additional peaks appeared in some spectra and caused strong interference with the carotenoporphyrin fluorescence peaks. In particular, these peaks completely distorted some of the spectra from the gastrointestinal system, the skin and the abdominal wall. The prominent peak at 672 nm, with a minor peak above 700 nm ( Figure 2B ), may be attributed to degradation products of chlorophyll a from the mouse food pellets. The products mainly responsible for the fluorescence are pheophorbide a and/or pheophytin a (Weagle et al, 1988) . On fluorescence analysis, the food pellets were confirmed to contain large amounts of chlorophyll. Furthermore, the faeces were analysed in a few animals, and were also found to exhibit a strong fluorescence, consistent with a high chlorophyll degradation product content. The less clearly understood peak at about 596 nm ( Figure 2C ) might be attributed to bacterially synthesized porphyrins (Harris and Werkhaver, 1987) or to a metalloporphyrin (Moan, 1986 , Plus, 1992 . The small peak occasionally occurring at approximately 630 nm ( Figure 2D ) is, most likely, due to endogenous porphyrins.
In conclusion, CPs appear to be attractive tumour-localizing substances for fluorescence diagnostics of malignant tumours. First of all, the binding of a carotene moiety to a tetraphenylporphyrin results in an efficient quenching of porphyrin triplet states, thus hampering any unwanted photodynamic action of the porphyrin. Moreover, the CPs display a tumour to normal fluorescence ratio as high as 10 or even better for CP(OMe)3 . In addition, all normal tissues analysed by LIF show a consistently lower CP(Me)3 and CP(OMe)3 accumulation, as compared with tumour, throughout the period 3-96 h past-injection interval. One notable exception is the liver, which yields CP-fluorescence signals about as intense as those observed for tumour exterior, with no apparent decrease up to 96 h after i.v. administration of CP(Me)3. Previous pharmacokinetic studies showed that the CP content in liver is approximately constant for at least 8 weeks after i.v. administration. Such a high accumulation and prolonged retention of CP in liver may represent a major limitation to the use of CPs as photodiagnostic agents in vivo. We are presently addressing this problem by studying the pharmacokinetic properties of CPs with different chemical structure and degree of hydro-and lipophilicity, in order to enhance the clearance from liver and other normal tissues without significantly reducing their affinity for tumours.
